Short- and long-term outcomes in isolated penetrating aortic ulcer disease.


Journal

Journal of vascular surgery
ISSN: 1097-6809
Titre abrégé: J Vasc Surg
Pays: United States
ID NLM: 8407742

Informations de publication

Date de publication:
07 2020
Historique:
received: 10 06 2019
accepted: 12 09 2019
pubmed: 25 2 2020
medline: 1 12 2020
entrez: 25 2 2020
Statut: ppublish

Résumé

The optimum management of isolated penetrating aortic ulceration (PAU), with no associated intramural hematoma or aortic dissection is not clear. We evaluate the short- and long-term outcomes in isolated PAU to better inform management strategies. We conducted a retrospective review of 43 consecutive patients (mean age, 72.2 years; 26 men) with isolated PAU (excluding intramural hematoma/aortic dissection) managed at a single tertiary vascular unit between November 2007 and April 2019. Twenty-one percent had PAU of the arch, 62% of the thoracic aorta, and 17% of the abdominal aorta. Conservative and surgical groups were analyzed separately. Primary outcomes included mortality, PAU progression, and interventional complications. Initially, 67% of patients (29/43) were managed conservatively; they had significantly smaller PAU neck widths (P = .04), PAU depths (P = .004), and lower rates of associated aneurysmal change (P = .004) compared with those initially requiring surgery. Four patients (4/29) initially managed conservatively eventually required surgical management at a mean time interval of 49.75 months (range, 9.03-104.33 months) primarily owing to aneurysmal degeneration. Initially, 33% of patients (14/43) underwent surgical management; 7 of the 14 procedures were urgent. Of the 18 patients, 17 eventually managed with surgical intervention had an endovascular repair; 2 of the 17 endovascular cases involved supra-aortic debranching, six used scalloped, fenestrated, or chimney stents. The overall long-term mortality was 30% (mean follow-up, 48 months; range, 0-136 months) with no significant difference between the conservatively and surgically managed groups (P = .98). No aortic-related deaths were documented during follow-up in those managed conservatively. There was no in-hospital mortality after surgical repair. Of these 18 patients, two required reintervention within 30 days for type I or III endoleaks. Among the 18 patients, seven died during follow-up (mean survival, 90.24 months; range, 66.48-113.88) with 1 of the 18 having a confirmed aortic-related death. Isolated, asymptomatic, small PAUs may be safely managed conservatively with regular surveillance. Those with high-risk features or aneurysmal progression require complex strategies for successful treatment with acceptable long-term survival.

Sections du résumé

BACKGROUND
The optimum management of isolated penetrating aortic ulceration (PAU), with no associated intramural hematoma or aortic dissection is not clear. We evaluate the short- and long-term outcomes in isolated PAU to better inform management strategies.
METHODS
We conducted a retrospective review of 43 consecutive patients (mean age, 72.2 years; 26 men) with isolated PAU (excluding intramural hematoma/aortic dissection) managed at a single tertiary vascular unit between November 2007 and April 2019. Twenty-one percent had PAU of the arch, 62% of the thoracic aorta, and 17% of the abdominal aorta. Conservative and surgical groups were analyzed separately. Primary outcomes included mortality, PAU progression, and interventional complications.
RESULTS
Initially, 67% of patients (29/43) were managed conservatively; they had significantly smaller PAU neck widths (P = .04), PAU depths (P = .004), and lower rates of associated aneurysmal change (P = .004) compared with those initially requiring surgery. Four patients (4/29) initially managed conservatively eventually required surgical management at a mean time interval of 49.75 months (range, 9.03-104.33 months) primarily owing to aneurysmal degeneration. Initially, 33% of patients (14/43) underwent surgical management; 7 of the 14 procedures were urgent. Of the 18 patients, 17 eventually managed with surgical intervention had an endovascular repair; 2 of the 17 endovascular cases involved supra-aortic debranching, six used scalloped, fenestrated, or chimney stents. The overall long-term mortality was 30% (mean follow-up, 48 months; range, 0-136 months) with no significant difference between the conservatively and surgically managed groups (P = .98). No aortic-related deaths were documented during follow-up in those managed conservatively. There was no in-hospital mortality after surgical repair. Of these 18 patients, two required reintervention within 30 days for type I or III endoleaks. Among the 18 patients, seven died during follow-up (mean survival, 90.24 months; range, 66.48-113.88) with 1 of the 18 having a confirmed aortic-related death.
CONCLUSIONS
Isolated, asymptomatic, small PAUs may be safely managed conservatively with regular surveillance. Those with high-risk features or aneurysmal progression require complex strategies for successful treatment with acceptable long-term survival.

Identifiants

pubmed: 32089340
pii: S0741-5214(19)32501-7
doi: 10.1016/j.jvs.2019.09.039
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

84-91

Investigateurs

Alun Davies (A)
Usman Jaffer (U)
David Nott (D)
Joseph Shalhoub (J)
Nigel Standfield (N)
Christopher Aylwin (C)

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Crown Copyright © 2019. Published by Elsevier Inc. All rights reserved.

Auteurs

Safa Salim (S)

Imperial Vascular Unit, St. Mary's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Rossella Locci (R)

Bradford Teaching Hospitals, NHS Foundation Trust, Bradford, United Kingdom.

Guy Martin (G)

Imperial Vascular Unit, St. Mary's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Richard Gibbs (R)

Imperial Vascular Unit, St. Mary's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Michael Jenkins (M)

Imperial Vascular Unit, St. Mary's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Mohamad Hamady (M)

Department of Surgery and Cancer, Imperial College London, London, United Kingdom; Department of Interventional Radiology, St Mary's Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom.

Celia Riga (C)

Imperial Vascular Unit, St. Mary's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom.

Colin Bicknell (C)

Imperial Vascular Unit, St. Mary's Hospital, London, United Kingdom; Department of Surgery and Cancer, Imperial College London, London, United Kingdom. Electronic address: colin.bicknell@nhs.net.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH